Products for Research Use Only

PROTAC ERα Degrader-13

CAT: 0804-HY-178961Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-178961Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PROTAC ERα Degrader-13 is an orally active PROTAC molecule that efficiently and selectively degrades ERα (DC50 = 3.78 nM). PROTAC ERα Degrader-13 has the characteristics of strong anti proliferation (IC50 = 0.6 nM), induction of apoptosis, and overcoming drug resistance in MCF-7 cells. PROTAC ERα Degrader-13 has good safety and no significant organ toxicity. PROTAC ERα Degrader-13 can be used for cancer research. (Pink: ERα Ligand ; Blue: VHL Ligand (HY-125845) ; Black: Linker (HY-W040168) )
Target
Apoptosis; Estrogen Receptor/ERR; PROTACs
Related Pathways
Apoptosis; PROTAC; Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
CC/C(C1=CC=C(F)C=C1Cl)=C(C2=CC=C(/C=C/C(NCCOCCOCCC(N[C@H](C(N3C[C@H](O)C[C@H]3C(NCC4=CC=C(C5=C(C)N=CS5)C=C4)=O)=O)C(C)(C)C)=O)=O)C=C2)\C6=CC(C=NN7)=C7C=C6
Molecular Formula
C55H61ClFN7O7S
Molecular Weight
1018.63
References & Citations
[1]Bao X, et al. Highly potent and selective degrader targeting ERα to improve the treatment outcomes of breast cancer. Eur J Med Chem. 2026 Jan 5;301:118199.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERα; von Hippel-Lindau (VHL)

Popular Products